<unk>  is an antiemetic, neurokinin-1 receptor antagonist that is FDA approved for the prophylaxis of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin and nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). Its also, indicated for the prevention of postoperative nausea and vomiting (PONV).   Common adverse reactions include alopecia, anorexia, asthenia/fatigue, constipation, diarrhea, headache, hiccups, nausea, hypotension, pruritus, pyrexia.
Aprepitant
Eptifibatide
Iofendylate
Oprelvekin
Prasugrel
Bepotastine Besilate
Defibrotide
Ambrisentan